TI - The clinical importance of fibroblast growth factor 23 on advanced non-small cell lung cancer patients without druggable alterations in genes as EGFR or ALK or ROS1 Fibroblast growth factor 23
PT - Journal Article
DP - 2020
TA - EJMI
PG - 365-369
VI - 4
IP - 3
AID - 2020.60165 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.2020.60165
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2020 4(3): 365